GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Physical Therapy Inc (NYSE:USPH) » Definitions » Intrinsic Value: Projected FCF
中文

US Physical Therapy (US Physical Therapy) Intrinsic Value: Projected FCF

: $67.63 (As of Today)
View and export this data going back to 1992. Start your Free Trial

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-23), US Physical Therapy's Intrinsic Value: Projected FCF is $67.63. The stock price of US Physical Therapy is $103.39. Therefore, US Physical Therapy's Price-to-Intrinsic-Value-Projected-FCF of today is 1.5.

The historical rank and industry rank for US Physical Therapy's Intrinsic Value: Projected FCF or its related term are showing as below:

USPH' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.02   Med: 1.4   Max: 1.86
Current: 1.53

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of US Physical Therapy was 1.86. The lowest was 1.02. And the median was 1.40.

USPH's Price-to-Projected-FCF is ranked worse than
56.07% of 305 companies
in the Healthcare Providers & Services industry
Industry Median: 1.28 vs USPH: 1.53

US Physical Therapy Intrinsic Value: Projected FCF Historical Data

The historical data trend for US Physical Therapy's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Physical Therapy Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.21 64.76 67.74 66.76 67.63

US Physical Therapy Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.76 66.13 74.13 68.54 67.63

Competitive Comparison

For the Medical Care Facilities subindustry, US Physical Therapy's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Physical Therapy Price-to-Projected-FCF Distribution

For the Healthcare Providers & Services industry and Healthcare sector, US Physical Therapy's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where US Physical Therapy's Price-to-Projected-FCF falls into.



US Physical Therapy Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get US Physical Therapy's Free Cash Flow(6 year avg) = $66.52.

US Physical Therapy's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*66.52496+476.194*0.8)/14.998
=67.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


US Physical Therapy  (NYSE:USPH) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

US Physical Therapy's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=103.39/67.628764442425
=1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


US Physical Therapy Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of US Physical Therapy's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


US Physical Therapy (US Physical Therapy) Business Description

Traded in Other Exchanges
Address
1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Executives
Clayton Trier director 1300 WEST SAM HOUSTON PARKWAY SOUTH, SUITE 300, HOUSTON TX 77042
Kathleen A Gilmartin director 1300 W SAM HOUSTON PKWY S, SUITE 300, HOUSTON TX 77042
Nancy Ham director U.S. PHYSICAL THERAPY INC., 1300 W SAM HOUSTON PARKWAY - SUITE 100, HOUSTON TX 77042
Richard Binstein officer: EVP Gen'l Counsel & Secretary 3733 ROSEMONT PASS, NEWTOWN SQUARE PA 19037
Edward L Kuntz director
Graham D. Reeve officer: COO 1300 W. SAM HOUSTON PARKWAY, SUITE 300, HOUSTON TX 77042
Harris Bernard A Jr director 3411 ERIN KNOLL CT, HOUSTON TX 77059
Carey P Hendrickson officer: Chief Financial Officer, other: Effective 11/9/2020 400 S. RECORD STREET, DALLAS TX 75202
Eric Joseph Williams officer: Chief Operations Officer 1300 SAM HOUSTON PARKWAY W, SUITE 300, HOUSTON TX 77042
Harry S Chapman director 4626 DRAKE FALLS COURT, KATY TX 77450
Christopher J Reading officer: Chief Operating Officer
Mark J Brookner director 1300 W SAM HOUSTON PARKWAY S, STE 300, HOUSTON TX 77042
Regg E. Swanson director, Director 1737 BURKE HOLLOW ROAD, NOLENSVILLE TN 37037
Anne Motsenbocker director 1300 W SAM HOUSTON PARKWAY, SUITE 300, HOUSTON TX 77042
Glenn Mcdowell officer: Chief Operating Officer 1300 W. SAM HOUSTON PKWY S., SUITE 300, HOUSTON TX 77042